Salute e Benessere

Embla Medical hf: The Centers for Medicare & Medicaid Services (CMS) grants…

The finalized policy, which will take effect on 1 September 2024, does not automatically create access for every person currently classified as a K2 amputee. Treating healthcare professionals will have to establish through medical documentation that a bionic knee (MPK or microprocessor-controlled knee) or other K3 knee would improve the patient's functional health outcomes, help them accomplish activities of daily living, and that lower-level knee options have been considered and ruled out. In…
PR Newswire
18/07/2024

dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

The transaction includes dsm-firmenich's MEG-3 business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production facilities in Piura, Peru and Mulgrave, Canada. The MEG-3 business represented approximately €170 million sales in 2023, with approximately 200 employees who will transfer to KD Pharma. The transaction includes dsm-firmenich's MEG-3 business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production...
PR Newswire
18/07/2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities…

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – July 18, 2024 – 06:00 PM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on July 17, 2024, from Atlas Special Opportunities, LLC indicating that as of July 17, 2024, it...
Nasdaq GlobeNewswire
18/07/2024

Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and…

Idorsia will publish its Half Year 2024 Financial Reporting on Thursday July 25, 2024, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day.Date: Thursday, July 25, 2024 Time: 15:00 CEST / 14:00 BST / 09:00 EDT The call will start with presentations by senior management, followed by a Q&A session.To support your preparations, the consensus estimates can be found under:www.idorsia.com/consensus-estimate...
Nasdaq GlobeNewswire
18/07/2024

Cancer Therapeutics Market is Projected to Attain a USD 299.13 Billion Valuation…

Download a detailed overview:https://www.skyquestt.com/sample-request/cancer-therapeutics-market Download a detailed overview: https://www.skyquestt.com/sample-request/cancer-therapeutics-market Cancer Therapeutics Market Overview: Segments covered in Cancer Therapeutics Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/cancer-therapeutics-market Rising Incidence of Lung Cancer Due to High Air Pollution...
PR Newswire
18/07/2024

Biotechnology Market: Surging Investments and Infrastructure Development Propel…

Biotechnology and related products are required to meet established regulatory guidelines and standards. The major federal agencies in the US responsible for administering the required standards are the Animal and Plant Health Inspection Service (APHIS), US. The Coordinated Framework for the Regulation of Biotechnology outlines a government framework for evaluating products developed using modern biotechnology. This provision is based on existing laws developed to protect public health and the…
PR Newswire
18/07/2024

Biologics Market: Surging with 10.40% CAGR Amid Fewer Chronic Cases | SkyQuest…

The global biologics market plays an important role in the development of new therapies for various diseases. It aims to improve patient outcomes and improve quality of life. While there are driving forces such as the increasing incidence of chronic diseases and advances in biotechnology, there are also inhibiting factors such as high costs and product development though. The global biologics market plays an important role in the development of new therapies for various diseases. It aims to...
PR Newswire
18/07/2024

Global Health Information Exchange Market: USD 2.8B Projection, USD 1.7B Base…

Browse in-depth TOC on "Health Information Exchange Market" Browse in-depth TOC on "Health Information Exchange Market" 526 - Tables 53 - Figures 435 - Pages The updated version of the Health Information Exchange Market report provides comprehensive insights from historical data covering 2022 and 2023 to forecasts up to 2029, with a focus on the CAGR from 2024 to 2029. Key updates include: Market Overview:Features include patent analysis, key conferences & events,...
PR Newswire
18/07/2024

Growth Hormone Deficiency Market Poised to Reach US$ 7 Billion by 2034, Driven…

A notable trend is the increasing focus on digital health solutions. Telemedicine and digital platforms are facilitating remote patient monitoring, enhancing treatment adherence, and improving overall patient outcomes. These technologies are particularly beneficial in regions with limited healthcare access, thereby expanding the reach of growth hormone deficiency therapies. A notable trend is the increasing focus on digital health solutions. Telemedicine and digital platforms are facilitating...
PR Newswire
18/07/2024

Active Pharmaceutical Ingredients CDMO Market to be dominated by Oncology…

The Active Pharmaceutical Ingredients CDMO Market research provides in-depth details on important variables such as motivating factors and obstacles that are expected to determine the market's future growth. Along with a thorough analysis of the competitive landscape, the report also includes available opportunities for stakeholders to invest in the Active Pharmaceutical Ingredients CDMO Market. Both qualitative and quantitative characteristics of the industry have also been covered in the…
PR Newswire
18/07/2024

Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024

Houston, Texas and Tuebingen, Germany, July 18, 2024–Immatics N.V.(NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced that the first proof-of-concept clinical data for its next-generation, half-life extended TCR Bispecific molecule, TCER® IMA401 (MAGEA4/8), will be presented during an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2024...
Nasdaq GlobeNewswire
18/07/2024

Novo Holdings Portfolio Company Invetx to be Acquired by Dechra Pharmaceuticals

Novo Holdings co-led Invetx's Series B financing round in 2022, which enabled Invetx to advance its mAb pipeline and pursue market approvals for therapeutics targeting chronic and serious diseases in dogs and cats. This investment reflects Novo Holdings' strong track record of investing in and nurturing the development of innovative life sciences companies that are at the forefront of the development of cutting-edge solutions. Invetx was incubated by Anterra Capital, a Boston and Amsterdam based…
PR Newswire
18/07/2024

New data for Roche's Susvimo demonstrates sustained efficacy in two serious…

Two-year Phase III data presented at ASRS 2024 show Susvimo's potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR)Safety data were consistent with the known safety profile for Susvimo in people with DME and DRAdditionally, the US FDA has accepted the filing application for Susvimo in DME and DR based on one-year Pagoda and Pavilion study dataSusvimo is a unique therapeutic approach that provides continuous delivery of...
Nasdaq GlobeNewswire
18/07/2024

Haier Smart Home Intends to Acquire Electrolux South Africa's Water Heater…

The acquisition is an important step in the strategic implementation of Haier Smart Home's development in African market. The acquisition is an important step in the strategic implementation of Haier Smart Home's development in African market. Leveraging Kwikot's extensive HVAC channel and service coverage, Haier Smart Home will realize synergies in product and supply chain management to expand Kwikot's water heater lineups and unlock potentials in solar water heaters and water purifiers...
PR Newswire
18/07/2024

Cast Saw Devices Market to be worth US$ 273.6 Million by 2031 | States…

Cast saw devices are specialized tools used for safely and effectively removing orthopedic casts. These devices typically feature oscillating blades designed to cut through hard materials like plaster or fiberglass without harming the underlying skin. The global increase in orthopedic conditions, such as arthritis, degenerative disorders, and fractures, is a key factor augmenting the cast saw devices market growth. These conditions make casts and medical casting saw devices critical care…
PR Newswire
18/07/2024

Anal Irrigation System Market to Reach USD 443.6 Million by 2031, Driven by…

With the rapidly changing lifestyles, people have been inclined more toward the consumption of alcohol and smoking. Such lifestyle habits are propelling the cases of cancer worldwide. Owing to a lack of eating habits, excessive alcohol consumption, smoking, and many more factors, the prevalence of colorectal cancer is expected to increase during the forecast period. With the rapidly changing lifestyles, people have been inclined more toward the consumption of alcohol and smoking. Such...
PR Newswire
18/07/2024

Foreign Affairs Minister Mélanie Joly announces Canada's intention to join…

George Bickerstaff, Chairperson of IVI's BOT, said: "On behalf of the BOT, it is my great pleasure to share that the Board has approved Canada's request to join IVI as a State Party. We look to our member countries for guidance on how best to serve the international community and deliver on not only IVI's goals but their contributions to the Sustainable Development Goals as well. With Canada's membership, IVI and its Global Council will gain a critical new voice to champion equitable global…
PR Newswire
18/07/2024

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing…

Pulmonary fibrosis is a chronic lung condition that is progressive and life-limiting. Untreated, patients can have a lifespan as short as 5 years from diagnosis, and yet despite this, often wait up to 2 years for diagnosis. The key to the best survival for patients with fibrosing lung disease is the earliest initiation of treatment, but identifying patients eligible for treatment based on imaging can be challenging, even for experts. Pulmonary fibrosis is a chronic lung condition that is...
PR Newswire
18/07/2024

Diamyd Medical receives second U.S. FDA Fast Track designation for Diamyd® - for…

For further information regarding Fast Track drug development programs, please refer to the Guidance for Industry: Expedited Programs for Serious Conditions - Drugs and Biologics at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf For further information regarding Fast Track drug development programs, please refer to the Guidance for Industry: Expedited Programs for Serious Conditions - Drugs and Biologics at...
PR Newswire
18/07/2024

Interim report Q2/2024: Enzymatica builds momentum for expansion

"Many factors now point to a favorable pathway for Enzymatica. We are making great strides in research, we have received the MDR certification, we are garnering international interest and we are seeing signs of regulatory developments that could be beneficial to us. At the same time, we need to expand our partner network, which does not happen overnight. Registrations in new countries will delay the launch in the largest international markets and we want to increase our research efforts…
PR Newswire
18/07/2024

Bavarian Nordic Receives EMA Filing Acceptance and Validation of the MAA for its…

EMA will now initiate its centralized review procedure under accelerated assessment for Bavarian Nordic's chikungunya vaccineCOPENHAGEN, Denmark, July 18, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA), which was submitted in June 2024 for CHIKV VLP, the Company's vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of...
Nasdaq GlobeNewswire
18/07/2024

First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches…

Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosisStrong first half net sales growth of 7.4%* year on year Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported on Thursday significant progress in its pipeline across key therapeutic areas as it reached major milestones in the first half of the year.“We are stepping up our investments in...
Nasdaq GlobeNewswire
18/07/2024

BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards

The APEX Awards, now in their 36th year, recognize outstanding work by professional communicators in areas such as graphic design, editorial content, and overall communications excellence. With over 1,100 entries this year, the competition was fierce, making these nine wins a testament to the continued leadership and innovation in the field by BioWorld. The APEX Awards, now in their 36th year, recognize outstanding work by professional communicators in areas such as graphic design, editorial...
PR Newswire
18/07/2024

Implantica launches RefluxStop™ advanced education program in Spain

Dr. Juan Carlos Ruiz de Adana at Hospital Universitario de Getafe, says, "It's been an immense pleasure to participate in such engaging discussions with other RefluxStopTM users and thought leaders in Spain and other parts of Europe. As an anti-reflux expert, I am excited to see a new technology that has significant potential to improve patient outcomes, demonstrated in my team's first-hand experience using the RefluxStop device over the past year. Such ongoing training and exchanging ideas…
PR Newswire
18/07/2024
Altri  Comunicati